1. Anholt, R.R.H. (1986). Mitochondrial benzodiazepine receptors as potential modulators of intermediary metabolism.TiPS 7:506–511.
2. Arauja, D.M., Lapchak, P.A., Robitaille, Y., Gauthier, S. and Quirion, R. (1988). Differential alterations of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.J. Neurochem. 50:19114–1923.
3. Bachmann, C. and Colombo, J.P. (1984). Increase of tryptophan and 5-hydroxyindoleacetic acid in the brain of ornithine carbamoyl transferase deficient sparse-fur mice.Pediatr. Res. 18:372–375.
4. Bakker, M.H.M. and Foster, A.C. (1991). An investigation of the mechanisms of delayed neuron degeneration caused by direct injection of quinolinic acid into the rat striatumin vivo.Neuroscience 42:387–395.
5. Bassi, S., Ferrarese, C., Finola, M.G., Frattola, L., Iannucelli, M., Meregalli, S.et al. (1988). L-acetyl-carnitine in Alzheimer Disease (AD) and Senile Dementia of the Alzheimer Type (SDAT), inSenile Dementias (Second International Symposium) A. Agnoli, J. Cahn, N. Larsen and R. Mayeux, eds.), John Libbey Eurotext, Paris, pp. 461–466.